These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tolerance and biological activity of pentosan polysulfate after intramuscular or subcutaneous administration for ten days in human volunteers. Sié P, Albarede JL, Robert M, Bouloux C, Lansen J, Chigot C, Correll S, Thouvenot JP, Boneu B. Thromb Haemost; 1986 Feb 28; 55(1):86-9. PubMed ID: 2422778 [Abstract] [Full Text] [Related]
3. Absence of transplacental passage of pentosan polysulfate during mid trimester of pregnancy. Forestier F, Fischer AM, Daffos F, Beguin S, Diner H. Thromb Haemost; 1986 Dec 15; 56(3):247-9. PubMed ID: 2436327 [Abstract] [Full Text] [Related]
11. Influence on the clotting mechanism of sodium pentosan polysulfate (SP54) in comparison to commercial beef lung sodium heparin. Vinazzer H, Haas S, Stemberger A. Thromb Res; 1980 Oct 01; 20(1):57-68. PubMed ID: 6163222 [No Abstract] [Full Text] [Related]
12. Clinical application of Fragmin (FR-860) in hemodialysis: multicenter cooperative study in Japan. Suzuki T, Ota K, Naganuma S, Koshikawa S, Hirasawa Y, Nakagawa S, Otsubo O, Akizawa T. Semin Thromb Hemost; 1990 Oct 01; 16 Suppl():46-54. PubMed ID: 1962904 [Abstract] [Full Text] [Related]
13. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation. Fischer AM, Barrowcliffe TW, Thomas DP. Thromb Haemost; 1982 Apr 30; 47(2):104-8. PubMed ID: 6179182 [Abstract] [Full Text] [Related]
14. Comparison between commercial heparin, low molecular weight heparin and pentosan polysulfate on hemostasis and platelets in vivo. Esquivel CO, Bergqvist D, Björck CG, Nilsson B. Thromb Res; 1982 Nov 01; 28(3):389-99. PubMed ID: 6184845 [Abstract] [Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium. Modi NB, Kell S, Simon M, Vargas R. J Clin Pharmacol; 2005 Aug 01; 45(8):919-26. PubMed ID: 16027402 [Abstract] [Full Text] [Related]
16. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation]. Menges T, von Lessen A, Welters I, Wagner RM, Ruwoldt R, Boldt J, Hempelmann G. Infusionsther Transfusionsmed; 1994 Aug 01; 21(4):244-50. PubMed ID: 7950289 [Abstract] [Full Text] [Related]
17. Recombinant hirudin (HBW 023): biological data of ten patients with severe venous thrombo-embolism. Bridey F, Dreyfus M, Parent F, Bros A, Fischer AM, Camez A, Simonneau G, Duroux P, Meyer D. Am J Hematol; 1995 May 01; 49(1):67-72. PubMed ID: 7741141 [Abstract] [Full Text] [Related]
18. Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in man. Ryde M, Eriksson H, Tangen O. Thromb Res; 1995 May 01; 23(4-5):435-45. PubMed ID: 6172879 [No Abstract] [Full Text] [Related]
19. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting. Hertfelder HJ, Bös M, Weber D, Winkler K, Hanfland P, Preusse CJ. Semin Thromb Hemost; 2005 May 01; 31(4):426-40. PubMed ID: 16149021 [Abstract] [Full Text] [Related]
20. A sulphated polysaccharide--the effects in vivo and in vitro on the haemostatic system in healthy volunteers. Bergqvist D, Nilsson IM. Thromb Res; 1981 Aug 01; 23(3):309-15. PubMed ID: 7302931 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]